Clinical utility of robotic surgery (the da Vinci&reg; surgical system; standard and S) for the treatment of lung and mediastinal disease

Clinical utility of robotic surgery (the da Vinci&reg; surgical system; standard and S) for the treatment of lung and mediastinal disease - Clinical utility of robotic surgery for the treatment of lung and mediastinal disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004328

Enrollment

Registered

2010-10-05

Start date

2009-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung and mediastinal disease

Interventions

robotic surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: general condition good(possible of open thoracotomy)

Exclusion criteria

Exclusion criteria: general condition poor past history of the open thoracotomy

Design outcomes

Primary

Measure	Time frame
Robotic surgery is an effective surgical method.	—

Countries

Japan

Contacts

Public ContactKajiwara Naohiro

surgeru 1 thoracic surgery

kajiwara@tokyo-med.ac.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Clinical utility of robotic surgery (the da Vinci&amp;reg; surgical system; standard and S) for the treatment of lung and mediastinal disease